139 related articles for article (PubMed ID: 18035803)
1. Risk factors and bacterial profiles of urinary tract infections in patients with systemic lupus erythematosus.
Tsai YC; Hou CL; Yao TC; Chen LC; Jaing TH; Huang JL
Asian Pac J Allergy Immunol; 2007; 25(2-3):155-61. PubMed ID: 18035803
[TBL] [Abstract][Full Text] [Related]
2. Proteus mirabilis urinary tract infection and bacteremia: risk factors, clinical presentation, and outcomes.
Chen CY; Chen YH; Lu PL; Lin WR; Chen TC; Lin CY
J Microbiol Immunol Infect; 2012 Jun; 45(3):228-36. PubMed ID: 22572004
[TBL] [Abstract][Full Text] [Related]
3. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection.
Lau SM; Peng MY; Chang FY
J Microbiol Immunol Infect; 2004 Jun; 37(3):185-91. PubMed ID: 15221039
[TBL] [Abstract][Full Text] [Related]
4. Urinary tract infections and lupus erythematosus.
Hidalgo-Tenorio C; Jiménez-Alonso J; de Dios Luna J; Tallada M; Martínez-Brocal A; Sabio JM;
Ann Rheum Dis; 2004 Apr; 63(4):431-7. PubMed ID: 15020339
[TBL] [Abstract][Full Text] [Related]
5. Risk factors of all-cause in-hospital mortality among Korean elderly bacteremic urinary tract infection (UTI) patients.
Chin BS; Kim MS; Han SH; Shin SY; Choi HK; Chae YT; Jin SJ; Baek JH; Choi JY; Song YG; Kim CO; Kim JM
Arch Gerontol Geriatr; 2011; 52(1):e50-5. PubMed ID: 20579748
[TBL] [Abstract][Full Text] [Related]
6. Microbiological and immunological profile of patients with severe lupus flares related to bloodstream infections: a retrospective cohort study.
Torres-Ruiz J; Barrera-Vargas A; Ortiz-Hernández R; Alcocer-Varela J; Ponce-de-León A; Gómez-Martín D
Lupus; 2018 Feb; 27(2):312-318. PubMed ID: 28699377
[TBL] [Abstract][Full Text] [Related]
7. Lymphopaenia, anti-Ro/anti-RNP autoantibodies, renal involvement and cyclophosphamide use correlate with increased risk of herpes zoster in patients with systemic lupus erythematosus.
Hu SC; Lin CL; Lu YW; Chen GS; Yu HS; Wu CS; Lan CC
Acta Derm Venereol; 2013 May; 93(3):314-8. PubMed ID: 22983107
[TBL] [Abstract][Full Text] [Related]
8. Roles of host and bacterial virulence factors in the development of upper urinary tract infection caused by Escherichia coli.
Tseng CC; Wu JJ; Liu HL; Sung JM; Huang JJ
Am J Kidney Dis; 2002 Apr; 39(4):744-52. PubMed ID: 11920340
[TBL] [Abstract][Full Text] [Related]
9. [Infectious complications in systemic lupus erythematosus: a series of 146 patients].
Jallouli M; Frigui M; Marzouk S; Mâaloul I; Kaddour N; Bahloul Z
Rev Med Interne; 2008 Aug; 29(8):626-31. PubMed ID: 18440100
[TBL] [Abstract][Full Text] [Related]
10. Safety and efficacy of tumor necrosis factor alpha blockade in systemic lupus erythematosus: an open-label study.
Aringer M; Graninger WB; Steiner G; Smolen JS
Arthritis Rheum; 2004 Oct; 50(10):3161-9. PubMed ID: 15476222
[TBL] [Abstract][Full Text] [Related]
11. [Lupus nephritis as a factor of atherosclerosis risk in patients with systemic lupus erythematosus].
Serikova SIu; Kozlovskaia NL; Shilov EM
Ter Arkh; 2008; 80(6):52-8. PubMed ID: 18655477
[TBL] [Abstract][Full Text] [Related]
12. Profile and prognosis of febrile elderly patients with bacteremic urinary tract infection.
Tal S; Guller V; Levi S; Bardenstein R; Berger D; Gurevich I; Gurevich A
J Infect; 2005 May; 50(4):296-305. PubMed ID: 15845427
[TBL] [Abstract][Full Text] [Related]
13. Clinical factors associated with shock in bacteremic UTI.
Shigemura K; Tanaka K; Osawa K; Arakawa S; Miyake H; Fujisawa M
Int Urol Nephrol; 2013 Jun; 45(3):653-7. PubMed ID: 23616061
[TBL] [Abstract][Full Text] [Related]
14. Low complement levels in paediatric systemic lupus erythematosus and the risk of bacteraemia.
Hagen JP; Muller PC; Bredius RG; ten Cate R
BMJ Case Rep; 2013 Aug; 2013():. PubMed ID: 23966458
[TBL] [Abstract][Full Text] [Related]
15. Risk factors of mortality for salmonella infection in systemic lupus erythematosus.
Tsao CH; Chen CY; Ou LS; Huang JL
J Rheumatol; 2002 Jun; 29(6):1214-8. PubMed ID: 12064838
[TBL] [Abstract][Full Text] [Related]
16. Hospitalized Infections in Lupus: A Nationwide Study of Types of Infections, Time Trends, Health Care Utilization, and In-Hospital Mortality.
Singh JA; Cleveland JD
Arthritis Rheumatol; 2021 Apr; 73(4):617-630. PubMed ID: 33142044
[TBL] [Abstract][Full Text] [Related]
17. Infection in Thai patients with systemic lupus erythematosus: a review of hospitalized patients.
Wongchinsri J; Tantawichien T; Osiri M; Akkasilpa S; Deesomchok U
J Med Assoc Thai; 2002 Jun; 85 Suppl 1():S34-9. PubMed ID: 12188433
[TBL] [Abstract][Full Text] [Related]
18. Urinary proteins, vitamin D and genetic polymorphisms as risk factors for febrile urinary tract infection and relation with bacteremia: a case control study.
van der Starre WE; van Nieuwkoop C; Thomson U; Zijderveld-Voshart MS; Koopman JP; van der Reijden TJ; van Dissel JT; van de Vosse E
PLoS One; 2015; 10(3):e0121302. PubMed ID: 25807366
[TBL] [Abstract][Full Text] [Related]
19. Immunological aspects of biopsy-proven lupus nephritis in Bahraini patients with systemic lupus erythematosus.
Farid EM; Hassan AB; Abalkhail AA; El-Agroudy AE; Arrayed SA; Al-Ghareeb SM
Saudi J Kidney Dis Transpl; 2013 Nov; 24(6):1271-9. PubMed ID: 24231503
[TBL] [Abstract][Full Text] [Related]
20. Toward improved empiric management of moderate to severe urinary tract infections.
Leibovici L; Greenshtain S; Cohen O; Wysenbeek AJ
Arch Intern Med; 1992 Dec; 152(12):2481-6. PubMed ID: 1456860
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
